论文部分内容阅读
目的观察左乙拉西坦单药或添加治疗癫痫的临床效果。方法 82例癫痫患者,按照患者治疗意愿分为观察组和对照组,每组41例。对照组接受左乙拉西坦单药治疗,观察组接受左乙拉西坦添加治疗。观察两组临床疗效。结果观察组患者控制24例,有效16例,无效1例,临床治疗总有效率为97.6%,对照组患者控制19例,有效16例,无效6例,临床治疗总有效率为85.4%,观察组临床治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论在对癫痫患者实施治疗的过程中,左乙拉西坦添加治疗具有显著的治疗效果,可以促进患者的更好治疗,提高患者的康复速度,是首选的治疗方法 ,值得临床推广。
Objective To observe the clinical efficacy of levetiracetam monotherapy or add epilepsy treatment. Methods Eighty-two patients with epilepsy were divided into observation group and control group according to patients’ willingness to treat, with 41 cases in each group. The control group received levetiracetam monotherapy, and the observation group received levetiracetam supplementation. The clinical effects of two groups were observed. Results In the observation group, 24 cases were controlled, 16 cases were effective and 1 case was ineffective. The total effective rate was 97.6% in the control group, 19 cases in the control group, 16 cases were effective and 6 cases were ineffective. The total effective rate was 85.4% The total effective rate of clinical treatment was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion During the treatment of epileptic patients, levetiracetam addition has significant therapeutic effect, which can promote better treatment of patients and improve the recovery rate of patients. It is the first choice of treatment and worthy of clinical promotion.